Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercepharma.com
FiercePharma
Get the latest updates from FiercePharma directly as they happen.
Follow now 402 followers
Latest posts
Last updated about 20 hours ago
ASCO: Pfizer one-ups J&J with Talzenna combo's broad castration-sensitive prostate cancer win
about 20 hours ago
After winning a broader FDA label in metastatic castration-resistant prostate cancer, Pfizer’s...
ASCO: With bispecifics on its heels, Incyte positions Monjuvi combo for first-line DLBCL
about 20 hours ago
Seeking a share of the first-line diffuse B-cell lymphoma market, Incyte believes...
MannKind seeks long-awaited sales boost with inhaled insulin approval for kids
1 day ago
With a pediatric approval in hand for Afrezza, MannKind may finally have...
Why direct-to-patient is the future of pharma access
1 day ago
Gifthealth's CCO explains why DTP is no longer optional, - and how...
Pharma urged to modernize patient support as young adult cancer rates rise
2 days ago
Pharma companies need to strengthen and modernize patient support programs to reflect...
Fierce Pharma Asia—More China biotech hawkishness; Industry leaders meet Japan PM; Astellas’ roadmap
2 days ago
As China-developed assets gain more attention from biopharma dealmakers, some industry watchers...
Brand-name drug prices climb after launch in US, fall abroad amid MFN push: report
2 days ago
List prices for 25 top brand-name drugs rose an average of 81%...
ASCO: After Takeda’s defeat, Dizal picks up baton to take on J&J in EGFR lung cancer subtype
2 days ago
About three years after a phase 3 flop led Takeda to withdraw...
Philips adds a spoonful of Disney sugar to ease kids’ MRI anxieties
2 days ago
Philips has integrated animated Disney characters and stories into MRI machines to...
AstraZeneca gains 2nd bladder cancer nod in key expansion for Imfinzi
2 days ago
AstraZeneca has fired another shot in its bladder cancer competition with Merck’s...
Pharma leaders meet with PM Takaichi in push for Japan to retain R&D edge
3 days ago
A group of over 20 global pharma leaders met with Japan's Prime...
CVS restores coverage of Eli Lilly obesity med Zepbound, adds new pill Foundayo
3 days ago
The top pharmacy benefit manager in the U.S., CVS Caremark, will restore...